在严重的无塑性贫血中进行粒细胞输血
Roma V Rajput1, Vaani Shah2, Ruba N Shalhoub3
1Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Roma.Rajput@nih.gov.
Haematologica
|December 7, 2023
概括
在重度无形性贫血 (SAA) 患者的粒细胞输血 (GT) 显示,从初始输血后的总生存率为50%. 通过将患者连接到造血干细胞移植 (HSCT),GT可以改善生存率.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 严重无塑性贫血 (SAA) 患者面临高感染相关的发病率和死亡率.
- 颗粒细胞输血 (GT) 在SAA感染管理中的作用需要进一步描述.
研究的目的:
- 评估颗粒细胞输血 (GT) 对严重无形成性贫血 (SAA) 患者的生存结果的影响.
- 评估SAA患者GT相关的临床反应和并发症.
主要方法:
- 对28名SAA患者进行30次GT疗程的回顾性分析.
- 主要结局包括整体存活率 (OS),出院存活率和接受血造干细胞移植 (HSCT).
- 二次结果评估了使用分数系统在7天和30天的临床反应.
主要成果:
- 从最初的GT总生存率为50%,在最后的随访时有39%的人还活着 (中位数为551天).
- 64%的患者存活到出院; 86%的等待HSCT的患者接受了它.
- 30天后感染反应的患者的生存状况明显改善 (P=0.0004).
结论:
- 在SAA患者的GT感染改善或稳定可能会影响存活率.
- 虽然整体存活率仍然很低,并且可以发生与免疫接种,但GT可以作为通往HSCT的桥梁.
- 对于正在等待最终治疗的SAA患者来说,GT可能是一个有价值的辅助疗法.
更多相关视频
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
7.9K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
相关概念视频
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
